Bacimycin (clindamycin) / Baxter Healthcare - LARVOL DELTA

Therapies and Preventive Strategies for Recurrent Clostridium Difficile Infections - Episode 1: Defining Traditional Risk Factors for Developing C. Diff Infection (AJMC) - "Jessica Allegretti, MD, MPH: Yes. I'm a gastroenterologist, so our patients with inflammatory bowel disease are at significantly increased risk. These patients are atypical in that they tend to be younger and are community dwellers. They're not hospital dwellers. I'm always on high alert, especially when a patient with IBD [inflammatory bowel disease] is presenting with new or worsening symptoms....These are the things that we know to be risk factors for not only primary but also recurrent C difficile, so these are the questions I'm asking my patients when I'm assessing them."

Video

Updates In Therapeutics For Folliculitis Decalvans: A Systematic Review With Evidence Based Analysis (AHRS 2018) - "Treatment with combination of clindamycin and rifampicin demonstrated the best overall outcome according to response and level of evidence for moderate to severe FD."

Review